Jair Bomfim Santos

Jair Bomfim Santos

Auto-generated profile, based on publicly available information

Jair Bomfim Santos

Department of Public Health, Universidade Estadual de Feira de Santana, Feira de Santana, BA, Brazil

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2026 in Clinics
Verified
Journal Article
Open access
LOLucas Neves de Oliveira
Lucas Neves de Oliveira
RTRicardo Brianezi Tiraboschi
Ricardo Brianezi Tiraboschi
CSCaroline Santos Silva
Caroline Santos Silva
JSJair Bomfim Santos
Jair Bomfim Santos
MOMateus Neves de Oliveira
Mateus Neves de Oliveira
JJJosé Bessa Junior
José Bessa Junior
To evaluate the association between lipid profile, statin use, metabolic syndrome, and clinic. Prostate Enlargement (PE) in adult men attending a urology outpatient clinic. A cross-sectional study was conducted among 1117 men aged 40-years or older. Prostate volume was measured by ultrasonography; a volume ≥ 40 mL was considered the threshold for enlargement. Independent variables included lipid fractions, prescription-based statin use, and components of metabolic syndrome. Multivariate logistic regression models were applied, adjusted for age, hypertension, and medication exposure. The median age was 63-years (IQR: 55-71), and the median prostate volume was 34.0 mL (IQR: 26.0-48.0). Statin use was identified in 36.5% of the sample, and the prevalence of PE was 38.9%. Age was the only factor independently associated with PE (OR = 1.07; 95% CI: 1.05-1.09; p < 0.001). Metabolic syndrome was associated with PE in crude analysis; however, this association lost statistical significance after adjustment for potential confounders. Age was the only independent determinant of prostate enlargement in this metabolically controlled cohort. Lipid parameters and prescription-based statin use showed no adjusted association with prostate volume; however, the lack of detailed statin exposure data warrants cautious interpretation of these findings.